Recent studies in the UK have shown that Vitamin B3 raises the protein that is missing in people with FA. Research is still at an early stage and Professor Festenstein who is leading the research has warned against taking B3 until further studies are completed. To read more about the research, click here.
Posts in category Clinical Trials
In recent days FARA and Edison Pharmaceuticals have announced that a Phase 2B EPI-743 trial will commence in the very near future. This study will be a six month placebo-controlled, multi centre trial, there will also be a six month extension phase where all subjects will receive EPI-743. EPI-743 has shown great promise in previous studies where […]
A comprehensive article published in Dove Press Journal: Neuropsychiatric Disease and Treatment examines the current and emerging treatment options for the management of Friedreich’s Ataxia. Many current approaches are reviewed and possible future treatments are documented. The article does conclude that available evidence suggests that those with FA should be treated with Idebenone but that […]